News and Updates

The FDA has issued four compliance observations to Lannett, an Aurobindo Pharma subsidiary. Discover what this means for manufacturing and drug supply.

Researchers are testing psychedelic-assisted therapy for adjustment disorder in patients with serious illnesses. Discover the potential of this study.

Akeso receives China's green light to begin clinical trials for AK157D1, a promising B7-H3 targeting ADC designed to treat advanced solid tumors.

New clinical trials show potential for curing colorectal cancer without surgery. Learn how precision immunotherapy is transforming gastrointestinal care.

CureGene has dosed the first subject in an Australian Phase I trial for CG-0416, a novel oral drug targeting metabolic disorders. Learn about this study.

Can Chasteberry and seed cycling ease PMS? A recent clinical trial explores how this integrative approach impacts menstrual symptom severity. Read more.

Oncologists are shifting clinical trial designs to include patients with brain metastases, improving research accuracy and expanding treatment access.

Natco Pharma receives four observations from the US FDA following an inspection of its formulations unit. Learn the implications for the manufacturer.

A cancer patient's remarkable recovery through an experimental trial highlights the life-saving potential of precision medicine and targeted therapies.

A breakthrough new drug is showing unprecedented success in slowing early-stage dementia. Learn how this treatment targets brain plaques to save lives.